| Title |
Indomethacin for symptomatic patent ductus arteriosus in preterm infants
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2021
|
| DOI | 10.1002/14651858.cd013133.pub2 |
| Pubmed ID | |
| Authors |
Peter Evans, Deirdre O'Reilly, Jonathan N Flyer, Roger Soll, Souvik Mitra |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 6 | 19% |
| Canada | 4 | 13% |
| United States | 3 | 9% |
| Australia | 2 | 6% |
| Brazil | 1 | 3% |
| Kuwait | 1 | 3% |
| Kyrgyzstan | 1 | 3% |
| Turkey | 1 | 3% |
| Unknown | 13 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 69% |
| Practitioners (doctors, other healthcare professionals) | 6 | 19% |
| Scientists | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 177 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 22 | 12% |
| Researcher | 16 | 9% |
| Student > Postgraduate | 16 | 9% |
| Student > Master | 13 | 7% |
| Other | 12 | 7% |
| Other | 28 | 16% |
| Unknown | 72 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 35% |
| Nursing and Health Professions | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 2% |
| Sports and Recreations | 3 | 2% |
| Other | 15 | 8% |
| Unknown | 78 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2022.
All research outputs
#1,308,989
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#2,781
of 13,156 outputs
Outputs of similar age
#37,358
of 544,489 outputs
Outputs of similar age from Cochrane database of systematic reviews
#46
of 177 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 544,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.